title: Ambroxol-induced systemic contact dermatitis confirmed by positive patch test.
authors.forename: Susana
authors.initials: S
authors.lastname: Monzón
authors.forename: María
authors.initials: M
authors.lastname: Del Mar Garcés
authors.forename: Apolinar
authors.initials: A
authors.lastname: Lezaun
authors.forename: Juan
authors.initials: J
authors.lastname: Fraj
authors.forename: M
authors.initials: M
authors.lastname: Asunción Dominguez
authors.forename: Carlos
authors.initials: C
authors.lastname: Colás
mesh_terms: D015746:Abdominal Pain / Q000188:drug therapy; D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000368:Aged; D000551:Ambroxol / Q000008:administration & dosage / Q000009:adverse effects / Q000737:chemistry; D017449:Dermatitis, Allergic Contact / Q000175:diagnosis* / Q000188:drug therapy / Q000209:etiology / Q000503:physiopathology; D003875:Drug Eruptions / Q000175:diagnosis* / Q000188:drug therapy / Q000209:etiology / Q000503:physiopathology; D004890:Erythema; D005076:Exanthema; D005260:Female; D006633:Histamine Antagonists / Q000627:therapeutic use; D006801:Humans; D010328:Patch Tests / Q000706:statistics & numerical data*; D011537:Pruritus
chemical_list: D000305:Adrenal Cortex Hormones; D006633:Histamine Antagonists; D000551:Ambroxol